Massive electronic trip records have recently been utilized to infer people's trips for healthcare. Many inferential methods were developed to derive healthcare trips by taxi using GPS trajectory records, but little attention is paid to public transit, as a common travel mode for healthcare. This paper proposes a method to fill this gap by mining a big data of smart transit cards with spatio-temporal constraints. We demonstrate and validate this method in Beijing, China. The inferred trips achieve a high degree of consistency, in space and time, with empirically observed trips from a survey. The inferred trips are further used to identify spatial disparities in transit-based access to healthcare, which might have been overlooked by health policy makers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.healthplace.2020.102405 | DOI Listing |
Paediatr Drugs
January 2025
Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Background: This study aimed to provide a comprehensive review of adverse events (AEs) associated with factor Xa (FXa) inhibitors in pediatric patients.
Methods: We searched PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and the European Union Clinical Trials Register for English-language records from the establishment of the database up to October 17, 2023.
Dig Dis Sci
January 2025
Ningxia Medical University, Xing Qing Block, Shengli Street No.1160, Yin Chuan City, 750004, Ningxia Province, People's Republic of China.
Background: Colon adenocarcinoma (COAD) is a leading cause of cancer-related mortality worldwide. Transient receptor potential vanilloid 4 (TRPV4), a calcium-permeable non-selective cation channel, has been implicated in various cancers, including COAD. This study investigates the role of TRPV4 in colon adenocarcinoma and elucidates its potential mechanism via the ferroptosis pathway.
View Article and Find Full Text PDFClin Rheumatol
January 2025
Department of Rheumatology, Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
Introduction/objectives: Sjogren's syndrome (SS) is a chronic inflammatory and difficult-to-treat autoimmune disease. Timosaponin AIII (TAIII), a plant-derived steroidal saponin, effectively inhibits cell proliferation, induces apoptosis, and exhibits anti-inflammatory properties. This study explored the mechanisms of action of TAIII in SS treatment by studying gut microbiota and short-chain fatty acids (SCFAs) using fecal metabolomics.
View Article and Find Full Text PDFSci China Life Sci
January 2025
China National Center for Bioinformation, Beijing, 100101, China.
Sci China Life Sci
January 2025
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!